Intended for healthcare professionals

Editorials

Nuts to you (… and you, and you)

BMJ 1998; 317 doi: https://doi.org/10.1136/bmj.317.7169.1332 (Published 14 November 1998) Cite this as: BMJ 1998;317:1332

Re: Nuts to you (… and you, and you)

Correction

Re: Jargin S.V. Cell Culture as a Testing System for Anti-Atherogenic Substances: A Brief Communication. Acta Pharmaceutica Sciencia 2008; 50(3): 237-240.

The above article was referenced in the previous Rapid Response:

Jargin SV. Serum atherogenicity testing on cell cultures: published data questioned. BMJ Rapid Response of 31 March 2010. http://www.bmj.com/rapid-response/2011/11/02/serum-atherogenicity-testin...

After a message from a reader that certain literature sources cited in the above article could not be found, I noticed that some references to conference abstracts have been incomplete. The website of the journal Acta Pharmaceutica Sciencia does not function; and e-mail messages are not responded. Therefore, this Correction message has been published here. I apologize for the inconvenience.

It is written in the reference list:

Aksenov D., Orekhova V., Kireev R., Andrianova I., Smirnov A., Sobenin I., Panasenko O. (2008). Effect of sex hormones on intracellular cholesterol accumulation and LDL aggregation. Atherosclerosis; 9: 20 (Abstract PO2-11).

Gorchakova T.V., Myasoedova V.A., Sobenin I. A., Orekhov A.N. (2006). The reduction of serum atherogenicity by natural anti-inflammatory drugs. Atherosclerosis; 7: 230 (Abstract Tu-P7:209).

Kireev R.A., Kuvshinova E., Andrianova I.V., Sobenin I.A., Orekhov A.N. (2006). Effect of sex hormones on atherosclerotic indices in primary culture of female cells. Atherosclerosis; 7: 250 (Abstract Tu-P7:296).

Korennaya V.V., Myasoedova V.A., Nikitina N.A., Sobenin I.A., Orekhov A.N. (2006) Bioflavonoid-rich botanicals reduce blood serum atherogenicity in perimenopausal women. Atherosclerosis; 7: 444 (Abstract We-P14:442).

Orekhov A.N., Sobenin I.A. (2006). Serum atherogenicity predicts the progression of atherosclerosis. Atherosclerosis; 7: 209 (Abstract Tu-P7:110).

It must be:

Aksenov D., Orekhova V., Kireev R., Andrianova I., Smirnov A., Sobenin I., Panasenko O. (2008). Effect of sex hormones on intracellular cholesterol accumulation and LDL aggregation. Abstracts of the 77th Congress of the European Atherosclerosis Society, 26-29 April 2008, Istanbul. Atherosclerosis Supplements; 9(1): 20 (Abstract PO2-11).

Gorchakova T.V., Myasoedova V.A., Sobenin I.A., Orekhov A.N. (2006). The reduction of serum atherogenicity by natural anti-inflammatory drugs Abstracts of the XIV International Symposium on Atherosclerosis, 18-22 June 2006, Rome. Atherosclerosis Supplements; 7(3): 230 (Abstract Tu-P7:209).

Kireev R.A., Kuvshinova E., Andrianova I.V., Sobenin I.A., Orekhov A.N. (2006). Effect of sex hormones on atherosclerotic indices in primary culture of female cells. Abstracts of the XIV International Symposium on Atherosclerosis, 18-22 June 2006, Rome. Atherosclerosis Supplements; 7(3): 250 (Abstract Tu-P8:296).

Korennaya V.V., Myasoedova V.A., Nikitina N.A., Sobenin I.A., Orekhov A.N. (2006) Bioflavonoid-rich botanicals reduce blood serum atherogenicity in perimenopausal women. Abstracts of the XIV International Symposium on Atherosclerosis, 18-22 June 2006, Rome. Atherosclerosis Supplements; 7(3): 444 (Abstract We-P14:442).

Orekhov A.N., Sobenin I.A. (2006). Serum atherogenicity predicts the progression of atherosclerosis. Abstracts of the XIV International Symposium on Atherosclerosis, 18-22 June 2006, Rome. Atherosclerosis Supplements; 7(3): 209 (Abstract Tu-P7:110).

The last open access article on this topic:

Jargin SV. Testing of serum atherogenicity in cell cultures: questionable data published. Ger Med Sci. 2012;10:Doc02. http://www.egms.de/static/en/journals/gms/2012-10/000153.shtml
Jargin SV.

Competing interests: No competing interests

08 December 2012
Sergei V. Jargin
researcher
Peoples' Friendship University of Russia
Clementovski per 6-82